Download PDF
Praxis Handreha 2022; 03(03): 136-137
DOI: 10.1055/a-1849-8096
Update

Beeinflussung des M. Dupuytren über die Ernährung und Mikronährstoffversorgung

Michael Dawils
› Further Information
Also available at
    Permissions and Reprints

Orientiert an den Risikofaktoren für die Entstehung eines Morbus Dupuytren, ist eine gezielte Analyse der Ernährungsgewohnheiten des Patienten sinnvoll. Schon kleine Veränderungen in der täglichen Routine der Nährstoffversorgung können das Risiko einer Verschlechterung oder eines Rezidivs reduzieren.



Publication History

Article published online:
20 July 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Ruettermann M, Hermann RM, Khatib-Chahidi K, Werker P. Morbus Dupuytren – Ätiologie und Behandlung. Dtsch Arztebl Int 2021; 118: 781-788
    PubMedGoogle Scholar
  • 2 Deutsche Diabetes Gesellschaft. . Deutscher Gesundheitsbericht Diabetes 2020 – Die Bestandsaufnahme (14.11.2019). Im Internet: https://www.deutsche-diabetes-gesellschaft.de Stand: 21.03.2022
  • 3 Kühn JP, Meffert P, Heske C. et al. Prevalence of fatty liver disease and hepatic iron overload in a northeastern German population by using quantitative MR imaging. Radiology 2017; 284: 706-716
    CrossrefPubMedGoogle Scholar
  • 4 Lean MEJ, Leslie WS, Barnes AC. et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 2019; 7: 344-355
    CrossrefPubMedGoogle Scholar
  • 5 Thom G, Messow CM, Leslie WS. et al. Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT). Diabet Med 2021; 38: e14395
    CrossrefPubMedGoogle Scholar
  • 6 Kloecker DE, Zaccardi F, Baldry E. et al. Efficacy of low- and very-low-energy diets in people with type 2 diabetes mellitus: A systematic review and meta-analysis of interventional studies. Diabetes Obes Metab 2019; 21: 1695-1705
    CrossrefPubMedGoogle Scholar
  • 7 Gow ML, Pham-Short A, Jebeile H. et al. Current perspectives on the role of very-low-energy diets in the treatment of obesity and type 2 diabetes in youth. Diabetes Metab Syndr Obes 2021; 14: 215-225
    CrossrefPubMedGoogle Scholar
  • 8 Gepner Y, Shelef I, Schwarzfuchs D. et al. Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial. Circulation 2018; 137: 1143-1157
    CrossrefPubMedGoogle Scholar
  • 9 Worm N. Beyond body weight-loss: Dietary strategies targeting intrahepatic fat in NAFLD. Nutrients 2020; 12: 1316
    CrossrefPubMedGoogle Scholar
  • 10 Gröber U. Arzneimittel und Mikronährstoffe. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 2018
    Google Scholar
  • 11 Prior RL, Gu L, Wu X. et al. Plasma antioxidant capacity changes following a meal as a measure of the ability of a food to alter in vivo antioxidant status. J Am Coll Nutr 2007; 26: 170-181
    CrossrefPubMedGoogle Scholar
  • 12 Boyer J, Liu RH. Apple phytochemicals and their health benefits. Nutrition Journal 2004; 3: 5
    CrossrefPubMedGoogle Scholar
  • 13 ORAC-Infoportal. ORAC-Vergleichslisten (2022). Im Internet: http://orac-info-portal.de/orac_produkte/orac_vergleichslisten/ Stand: 21.03.2022
  • 14 Lee CH, Fu Y, Yang SJ. et al. Effects of omega-3 polyunsaturated fatty acid supplementation on non-alcoholic fatty liver: A systematic review and meta-analysis. Nutrients 2020; 12: 2769
    CrossrefPubMedGoogle Scholar
  • 15 Park SK, Garland CF, Gorham ED. et al. Plasma 25-hydroxyvitamin D concentration and risk of type 2 diabetes and pre-diabetes: 12-year cohort study. PloS One 2018; 13: e0193070
    CrossrefPubMedGoogle Scholar
  • 16 Shaikh AS, Guo X. The impact of antiepileptic drugs on vitamin levels in epileptic patients. Current Pharmaceutical Biotechnology 2018; 19: 674-681
    CrossrefPubMedGoogle Scholar
  • 17 Holló A, Clemens Z, Kamondi A. et al. Correction of vitamin D deficiency improves seizure control in epilepsy: A pilot study. Epilepsy Behav 2012; 24: 131-133
    CrossrefPubMedGoogle Scholar
  • 18 Degiorgio CM, Hertling D, Curtis A. et al. Safety and tolerability of Vitamin D3 5000 IU/day in epilepsy. Epilepsy Behav 2019; 94: 195-197
    PubMedGoogle Scholar